Published in Am Rev Respir Dis on December 01, 1988
Exercise and cystic fibrosis. J R Soc Med (1995) 1.03
Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res (2006) 0.93
Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis? Arch Dis Child (2005) 0.84
Ventilatory response to exercise in adolescents with cystic fibrosis and mild-to-moderate airway obstruction. Springerplus (2014) 0.79
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Management of asthma: a consensus statement. Arch Dis Child (1989) 7.04
Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41
Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol (1998) 4.35
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38
Bronchial reactivity in cystic fibrosis. Pediatrics (1978) 2.70
Standards of pulmonary function in children. Am Rev Respir Dis (1969) 2.56
Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr (1981) 2.41
Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics (1977) 2.32
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet (1987) 2.05
Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03
Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics (1981) 2.00
Ultrastructure of airways in children with asthma. Histopathology (1978) 1.97
Hepatic abscess and cystic fibrosis. Postgrad Med J (1988) 1.77
Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66
Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64
Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr (1981) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Clinical and physiological assessment of asthmatic children treated with beclomethasone dipropionate. J Allergy Clin Immunol (1976) 1.59
Transit time analysis of the forced expiratory vital capacity in cystic fibrosis. Am Rev Respir Dis (1976) 1.58
Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr (1995) 1.56
Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics (1989) 1.54
Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics. Am Rev Respir Dis (1974) 1.53
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med (1985) 1.52
Pulmonary function in children with asthma at acute attack and symptom-free status. Am Rev Respir Dis (1969) 1.52
The approach to chronic cough in childhood. Ann Allergy (1988) 1.51
Mucociliary tracheal transport rates in man. J Appl Physiol (1975) 1.50
Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46
Airway closure in children. J Appl Physiol (1972) 1.45
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
Childhood asthma: a rational approach to treatment. Ann Allergy (1990) 1.44
Spacers in childhood asthma--is there one for all occasions? Ann Allergy (1990) 1.43
Maximal expiratory flows generated by rapid chest compression following end-inspiratory occlusion or expiratory clamping in young children. Eur Respir J (1995) 1.41
Noninvasive determination of cardiac output in patients with severe airflow limitation. Am J Respir Crit Care Med (1996) 1.40
Transcutaneous monitoring of oxygenation: what is normal? J Pediatr (1986) 1.37
Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37
Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.36
Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr (1985) 1.35
Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis (1979) 1.35
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr (1980) 1.34
Intermittent positive pressure respiration as a treatment in severe respiratory distress syndrome. Arch Dis Child (1965) 1.34
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
The response to exercise in normal and asthmatic children. J Pediatr (1978) 1.32
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31
High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics (1989) 1.30
Pulmonary function in infants and children following the acute neonatal respiratory distress syndrome. Bull Physiopathol Respir (Nancy) (1974) 1.30
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30
Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome. J Pediatr (1977) 1.30
Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics (1972) 1.29
Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics (1989) 1.27
Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. Am Rev Respir Dis (1977) 1.26
Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 1.26
Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am J Med (1973) 1.26
Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr (1985) 1.25
Relative sensitivity of methods for measuring airway resistance in asthmatic children. Ann Allergy (1969) 1.25
A comparison of infra-red and convective heating for newborn infants. Lancet (1966) 1.25
The Medicare Catastrophic Coverage Act: a post-mortem. Health Aff (Millwood) (1990) 1.25
Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. Am Rev Respir Dis (1976) 1.24
Chronic illness in infancy and parenting stress: a comparison of three groups of parents. J Pediatr Psychol (1990) 1.24
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros (2011) 1.23
Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol (1998) 1.22
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus. Am J Hum Genet (1992) 1.22
Pulmonary complications of congenital heart disease. Paediatr Respir Rev (2011) 1.22
The pulmonary syndrome of Wilson and Mikity. Pediatrics (1965) 1.21
Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Pediatr Infect Dis (1985) 1.19
Mechanism of hemoglobin desaturation during rapid-eye-movement sleep in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis (1980) 1.17
Physical signs in childhood asthma. Pediatrics (1976) 1.17
Bronchial hyperreactivity in cystic fibrosis and asthma. J Pediatr (1978) 1.16
Effects of ultrasonically nebulized distilled water on airway dynamics in children with cystic fibrosis and asthma. J Pediatr (1972) 1.16
Corticosteroids in status asthmaticus. J Pediatr (1980) 1.15
Sustained-release theophylline: a significant advance in the treatment of childhood asthma. J Pediatr (1982) 1.15
Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol (1986) 1.14
Comparative study of histamine and exercise challenges in asthmatic children. Am Rev Respir Dis (1978) 1.14
Effect of caffeine on control of breathing in infantile apnea. J Pediatr (1983) 1.12
Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr (1996) 1.12
Occult pulmonary abnormalities in asymptomatic asthmatic children. Chest (1977) 1.11
Maximal static pressures in healthy children. Respir Physiol (1983) 1.10
Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin. J Pediatr (1982) 1.09
Transit time analysis of the forced expiratory spirogram in growth. J Appl Physiol (1976) 1.09
Oral and inhaled salbutamol in the prevention of exercise-induced bronchospasm. Pediatrics (1980) 1.08
Clinical-physiologic correlations in acute asthma of childhood. Pediatrics (1991) 1.08
Knowledge of cystic fibrosis in patients and their parents. Pediatrics (1986) 1.07
Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol (1968) 1.06
Nebulized albuterol in acute childhood asthma: comparison of two doses. Pediatrics (1990) 1.05
Measurement of respiratory system resistance by forced oscillation in normal children: a comparison with spirometric values. Pediatr Pulmonol (1991) 1.05
Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child (1976) 1.04